The potential of mipomersen, an ApoB synthesis inhibitor, to reduce necessity for LDL-apheresis in patients with heterozygous familial hypercholesterolemia and coronary artery disease

2013 ◽  
Vol 14 (6) ◽  
pp. 691-697 ◽  
Author(s):  
Anja Vogt ◽  
Klaus G Parhofer
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Familial Hypercholesterolemia ◽  
Ldl Apheresis ◽  
Synthesis Inhibitor ◽  
Heterozygous Familial Hypercholesterolemia ◽  
Artery Disease ◽  
Apob Synthesis

Defining Patients at Extremely High Risk for Coronary Artery Disease in Heterozygous Familial Hypercholesterolemia

2012 ◽  
Vol 19 (4) ◽  
pp. 369-375 ◽  
Author(s):  
Takako Sugisawa ◽  
Tomonori Okamura ◽  
Hisashi Makino ◽  
Makoto Watanabe ◽  
Ichiro Kishimoto ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
High Risk ◽  
Familial Hypercholesterolemia ◽  
Heterozygous Familial Hypercholesterolemia ◽  
Artery Disease

Carotid Plaque Burden as a Measure of Subclinical Coronary Artery Disease in Patients With Heterozygous Familial Hypercholesterolemia

2013 ◽  
Vol 111 (9) ◽  
pp. 1305-1310 ◽  
Author(s):  
Gerrit L. ten Kate ◽  
Gert-Jan R. ten Kate ◽  
Stijn C.H. van den Oord ◽  
Admir Dedic ◽  
Anoeshka S. Dharampal ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Familial Hypercholesterolemia ◽  
Carotid Plaque ◽  
Plaque Burden ◽  
Heterozygous Familial Hypercholesterolemia ◽  
Artery Disease
Sign in / Sign up

Export Citation Format

Share Document